TAB1 and type 2 diabetes mellitus: Since enhanced basal activity of p38 has been correlated with type 2 diabetes [62], it may be possible that increased O-GlcNAcylation of TAB1 is the cause of both reduced contractility of cardiac myocytes and hyperglycemia.